CoChat

Expression of the G protein-coupled estrogen receptor (GPER) in endometriosis: a tissue microarray study

Open access

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

Background: The G protein-coupled estrogen receptor (GPER) is thought to be involved in non-genomic estrogen responses as well as processes such as cell proliferation and migration. In this study, we analyzed GPER expression patterns from endometriosis samples and normal endometrial tissue samples and compared these expression profiles to those of the classical sex hormone receptors. Methods: A tissue microarray, which included 74 samples from different types of endometriosis (27 ovarian, 19 peritoneal and 28 deep-infiltrating) and 30 samples from normal endometrial tissue, was used to compare the expression levels of the GPER, estrogen receptor (ER)-alpha, ER-beta and progesterone receptor (PR). The immunoreactive score (IRS) was calculated separately for epithelium and stroma as the product of the staining intensity and the percentage of positive cells. The expression levels of the hormonal receptors were dichotomized into low (IRS < 6) and high (IRS > =6) expression groups. Results: The mean epithelial IRS (+/−standard deviation, range) of cytoplasmic GPER expression was 1.2 (+/−1.7, 0–4) in normal endometrium and 5.1 (+/−3.5, 0–12) in endometriosis (p < 0.001), of nuclear GPER 6.4 (+/−2.6, 0–12) and 6.8 (+/−2.9, 2–12; p = 0.71), of ER-alpha 10.6 (+/−2.4, 3–12) and 9.8 (+/−3.0, 2–12; p = 0.26), of ER-beta 2.4 (+/−2.2; 0–8) and 5.6 (+/−2.6; 0–10; p < 0.001), and of PR 11.5 (+/−1.7; 3–12) and 8.1 (+/−4.5; 0–12; p < 0.001), respectively. The mean stromal IRS of nuclear GPER expression was 7.7 (+/−3.0; 2–12) in endometrium and 10.8 (+/−1.7; 6–12) in endometriosis (p < 0.001), of ER-alpha 8.7 (+/−3.1; 2–12) and 10.6 (+/−2.4; 2–12; p = 0.001), of ER-beta 1.8 (+/−2.0; 0–8) and 5.4 (+/−2.5; 0–10; p < 0.001), and of PR 11.7 (+/−0.9; 8–12) and 10.9 (+/−2.0; 3–12; p = 0.044), respectively. Cytoplasmic GPER expression was not detectable in the stroma of endometrium and endometriosis. The observed frequency of high epithelial cytoplasmic GPER expression levels was 50% (n = 30/60) in the endometriosis and none (0/30) in the normal endometrium samples (p < 0.001). High epithelial cytoplasmic GPER expression levels were more frequent in endometriomas (14/20, 70%; p = 0.01), as compared to peritoneal (9/18, 50%) or deep-infiltrating endometriotic lesions (7/22, 31.8%). The frequency of high stromal nuclear GPER expression levels was 100% (n = 74/74) in endometriosis and 76.7% (n = 23/30) in normal endometrium (p < 0.001). The frequency of high epithelial nuclear GPER expression levels did not differ between endometriosis and normal endometrium. Conclusions: The present data indicate a unique GPER expression pattern in endometriosis, especially in endometriomas as compared to the normal endometrium. The overexpression of GPER in endometriotic lesions suggests a potential role for GPER in the hormonal regulation of endometriosis, which should be taken into consideration for future hormonal treatment strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1477-7827-10-30

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Immunoreactivity Scores. Mean Immunoreactivity Scores (IRS) and 95% confidence intervals (error bars) for the expression of the (A) cytoplasmic expression of the G protein-coupled estrogen receptor (GPER cytoplasmic), the (B) nuclear expression of the G protein-coupled estrogen receptor (GPER nuclear), the (C) estrogen receptor alpha (ER-alpha), the (D) estrogen receptor beta (ER-beta), and the (E) progesterone receptor (PR) in the epithelium of normal endometrium (normal EM), ovarian endometriosis (ovarian ES), peritoneal endometriosis (peritoneal ES) and deep-infiltrating endometriosis (deep ES), as well as (F-J) the same receptors in the stroma of the mentioned tissues. Stromal cells did not show cytoplasmic GPER expression in endometrium and endometriosis and hence no corresponding chart is represented in this figure. Significance (*) was considered if p ≤ 0.0083 in the pairwise analysis according to a Bonferroni correction (α’ = α/6). Highly significant values (p ≤ 0.0016) are marked with (**).
Figure 1 Immunoreactivity Scores. Mean Immunoreactivity Scores (IRS) and 95% confidence intervals (error bars) for the expression of the (A) cytoplasmic expression of the G protein-coupled estrogen receptor (GPER cytoplasmic), the (B) nuclear expression of the G protein-coupled estrogen receptor (GPER nuclear), the (C) estrogen receptor alpha (ER-alpha), the (D) estrogen receptor beta (ER-beta), and the (E) progesterone receptor (PR) in the epithelium of normal endometrium (normal EM), ovarian endometriosis (ovarian ES), peritoneal endometriosis (peritoneal ES) and deep-infiltrating endometriosis (deep ES), as well as (F-J) the same receptors in the stroma of the mentioned tissues. Stromal cells did not show cytoplasmic GPER expression in endometrium and endometriosis and hence no corresponding chart is represented in this figure. Significance (*) was considered if p ≤ 0.0083 in the pairwise analysis according to a Bonferroni correction (α’ = α/6). Highly significant values (p ≤ 0.0016) are marked with (**).CC BY · PubMed Central
Figure 2 Representative histological tissue samples. Representative tissue samples of a normal endometrium (EM normal) microarray core (A1 – A5), an ovarian endometriosis (ES ovarian) tissue core (B1 – B5), a peritoneal endometriosis (ES peritoneal) tissue core (C1 – C5) and a deep-infiltrating endometriosis (ES deep) tissue core (D1 – D5). The samples were stained with hematoxylin/eosin (HE) (A1, B1, C1, D1), as well as by immunohistochemistry to detect the G protein-coupled estrogen receptor (GPER) (A2, B2, C2, D2), the estrogen receptor alpha (ER-alpha) (A3, B3, C3, D3), the estrogen receptor beta (ER-beta) (A4, B4, C4, D4) and the progesterone receptor (PR) (A5, B5, C5, D5) expression; Magnification × 200.
Figure 2 Representative histological tissue samples. Representative tissue samples of a normal endometrium (EM normal) microarray core (A1 – A5), an ovarian endometriosis (ES ovarian) tissue core (B1 – B5), a peritoneal endometriosis (ES peritoneal) tissue core (C1 – C5) and a deep-infiltrating endometriosis (ES deep) tissue core (D1 – D5). The samples were stained with hematoxylin/eosin (HE) (A1, B1, C1, D1), as well as by immunohistochemistry to detect the G protein-coupled estrogen receptor (GPER) (A2, B2, C2, D2), the estrogen receptor alpha (ER-alpha) (A3, B3, C3, D3), the estrogen receptor beta (ER-beta) (A4, B4, C4, D4) and the progesterone receptor (PR) (A5, B5, C5, D5) expression; Magnification × 200.CC BY · PubMed Central
Figure 3 Expression of the G protein-coupled estrogen receptor (GPER) in endometriosis, in normal endometrium and in the positive control. (A-C) Expression of the G protein-coupled estrogen receptor (GPER) in ovarian endometriosis with strong cytoplasmic and partial nuclear expression in the epithelium and strong nuclear expression in the stroma (A, 200×; B, 400×), compared to normal endometrium with positive nuclear and lack of cytoplasmic GPER expression (C, 200×). (D-E) GPER expression from breast carcinoma as a positive control with (D, 200×) strong cytoplasmic and negative nuclear GPER expression, as well as with (E, 200×) weak cytoplasmic and strong nuclear GPER expression.
Figure 3 Expression of the G protein-coupled estrogen receptor (GPER) in endometriosis, in normal endometrium and in the positive control. (A-C) Expression of the G protein-coupled estrogen receptor (GPER) in ovarian endometriosis with strong cytoplasmic and partial nuclear expression in the epithelium and strong nuclear expression in the stroma (A, 200×; B, 400×), compared to normal endometrium with positive nuclear and lack of cytoplasmic GPER expression (C, 200×). (D-E) GPER expression from breast carcinoma as a positive control with (D, 200×) strong cytoplasmic and negative nuclear GPER expression, as well as with (E, 200×) weak cytoplasmic and strong nuclear GPER expression.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

See all 43

Metadata

Authors
Samartzis, N., Samartzis, E. P., Noske, A., Fedier, A., Dedes, K. J., Caduff, R., Fink, D., & Imesch, P.
Affiliations
University Hospital Zurich (CH)
Corresponding author
Imesch, Patrick
Venue
Reproductive Biology and Endocrinology
Published
2012-04-20
Volume
10
Issue
1
Pages
30-30
ISSN
1477-7827 (ISSN-L)
OpenAlex
W2159557789
Cited by
43
References
29
Citations by year
2025: 4 · 2024: 2 · 2023: 2 · 2022: 6 · 2021: 4 · 2020: 5 · 2019: 1 · 2018: 1 · 2017: 1 · 2016: 3 · 2015: 5 · 2014: 3 · 2013: 5 · 2012: 1
FWCI
5.21
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Reproductive Biology and Endocrinology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
  • Universität Zürich
  • Universitätsspital Zürich
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
  • Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
Keywords
G protein-coupled estrogen receptor, endometriosis, non-genomic estrogen signaling, estrogen receptor alpha, estrogen receptor beta, progesterone receptor, deep infiltrating endometriosis, endometrioma, peritoneal endometriosis, endometrial epithelium, endometrial stroma, immunoreactive score, tissue microarray
MeSH terms
Adult, Endometriosis, Endometrium, Female, Humans, Middle Aged, Receptors, Estrogen, Receptors, Progesterone, Retrospective Studies, Receptors, G-Protein-Coupled, Tissue Array Analysis, Estrogen Receptor alpha, Estrogen Receptor beta

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Expression of the G protein-coupled estrogen receptor (GPER) in endometriosis: a tissue microarray study. https://app.cochat.ai/papers/10.1186/1477-7827-10-30
The paper
Samartzis, N., Samartzis, E. P., Noske, A., Fedier, A., Dedes, K. J., Caduff, R., Fink, D., & Imesch, P. (2012). Expression of the G protein-coupled estrogen receptor (GPER) in endometriosis: a tissue microarray study. Reproductive Biology and Endocrinology. https://doi.org/10.1186/1477-7827-10-30

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.